期刊
PSYCHOPHARMACOLOGY
卷 214, 期 2, 页码 537-548出版社
SPRINGER
DOI: 10.1007/s00213-010-2050-1
关键词
Alzheimer's disease; Schizophrenia; Muscarinic; Aricept; M-1 receptors; Place memory; Object memory
资金
- Alzheimer's Research Trust
- National Institutes of Mental Health
- Medical Research Council [G1000183B, G0001354B, G0001354] Funding Source: researchfish
Performance on the Cambridge Neuropsychological Test Automated Battery touchscreen paired-associates learning (PAL) test is predictive of Alzheimer's disease and impaired in schizophrenia and chronic drug users. An automated computer touchscreen PAL task for rats has been previously established. A pharmacologically validated PAL task for mice would be a highly valuable tool, which could be useful for a number of experimental aims including drug discovery. This study sought to investigate the effects of systemic administration of cholinergic agents on task performance in C57Bl/6 mice. Scopolamine hydrobromide (0.02, 0.2, and 2.0 mg/kg), dicyclomine hydrochloride (M-1 receptor antagonist; 2.0, 4.0, and 8.0 mg/kg), and donepezil hydrochloride (cholinesterase inhibitor; 0.03, 0.1, and 0.3 mg/kg) were administered post-acquisition in C57Bl/6 mice performing the PAL task. Scopolamine (0.2 and 2.0 mg/kg) and dicyclomine (at all administered doses) significantly impaired PAL performance. A significant facilitation in PAL was revealed in mice following donepezil administration (0.3 mg/kg). The present study shows that mice can acquire the rodent PAL task and that the cholinergic system is important for PAL task performance. M-1 receptors in particular are likely implicated in normal performance of PAL. The finding that mouse PAL can detect both impairments and improvements indicates that this task could prove to be a highly valuable tool for a number of experimental aims including drug discovery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据